Download PDF
1 / Pages

Other users also viewed these articles

Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society] Juan Pedro-Botet; Vivencio Barrios; Víctor Sánchez-Margalet; Juan Tamargo; Francisco Arrieta; José Mª Gámez; José Antonio Gimeno-Orna; Carlos Escobar; Juan José Gómez-Doblas; Antonio Pérez;
Endocrinol Diabetes Nutr. 2023;70 Supl 1:51-62
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial José Antonio Gimeno Orna; Ana Belén Mañas Martínez; Luis Rodríguez Padial; Manuel Anguita Sánchez; Vivencio Barrios; Javier Muñiz García; Antonio Pérez Pérez;
Endocrinol Diabetes Nutr. 2024;71:278-89
Faster-acting insulin aspart reduces glycaemic variability in sensor-augmented pump treated type 1 diabetes patients Jesus Moreno-Fernandez; Jose Alberto Garcia-Seco; Rita Virlaboa-Cebrian; Angela Maria Seco; Jose Ramon Muñoz-Rodriguez; Francisco Javier Gomez-Romero;
Endocrinol Diabetes Nutr. 2023;70:389-95